Cargando…
PAI‐1 induces Src inhibitor resistance via CCL5 in HER2‐positive breast cancer cells
Tyrosine kinase Src is overexpressed and activated in various tumors, including breast cancer, and is supposed to promote cancer formation and development. Src inhibitors have been developed recently and have shown efficacy in breast cancer as a single agent or in combination with anti‐HER2 antibodi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989873/ https://www.ncbi.nlm.nih.gov/pubmed/29601121 http://dx.doi.org/10.1111/cas.13593 |